Ocular Therapeutix Inc.
OCUL | NASDAQ
$6.78
-$0.19 (-2.73%)
Nov 2, 2026, 12:10 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 52.05M | 52.04M | 51.95M | 55.78M | 56.66M | 59.65M | 63.72M | 61.44M | 61.1M | 59.84M | 58.44M | 57.72M | 54.6M | 51.68M | 51.49M | 49.73M | 49.91M | 49.37M | 43.52M | 38.56M | 32.29M | 22.14M |
Cost of Revenue | 6.71M | 6.64M | 6.57M | 6.21M | 6M | 5.56M | 5.63M | 5.78M | 5.6M | 5.39M | 5.28M | 4.91M | 4.6M | 4.45M | 4.54M | 4.64M | 4.87M | 4.81M | 4.41M | 3.98M | 3.12M | 2.16M |
Gross Profit | 45.35M | 45.4M | 45.38M | 49.57M | 50.67M | 54.08M | 58.1M | 55.66M | 55.5M | 54.45M | 53.16M | 52.81M | 50M | 47.23M | 46.95M | 45.09M | 45.04M | 44.55M | 39.12M | 34.58M | 29.17M | 19.98M |
Operating Income | -313.91M | -299.44M | -270.02M | -250.83M | -228.13M | -204.08M | -171.78M | -141.26M | -114.47M | -91.45M | -82.38M | -81.69M | -84.02M | -83.37M | -78.65M | -77.34M | -75.33M | -75.64M | -78.04M | -74.33M | -68.81M | -66.46M |
Interest Income | 22.57M | 20.58M | 18.35M | 15.68M | 17.61M | 20.19M | 20.28M | 17.07M | 12.63M | 7.34M | 3.98M | 2.95M | 2.02M | 1.34M | 799K | 382K | 104K | 39K | 33K | 33K | 32K | 41K |
Pretax Income | -301.45M | -290.5M | -265.94M | -249.67M | -216.75M | -192.71M | -193.51M | -174.34M | -138.36M | -115.27M | -80.74M | -67.06M | -90.73M | -88.81M | -71.04M | -59.35M | -32.5M | -22.22M | -6.55M | -88.32M | -102.92M | -131M |
Net Income | -301.45M | -290.5M | -265.94M | -249.67M | -216.75M | -192.71M | -193.51M | -174.34M | -138.36M | -115.27M | -80.74M | -67.06M | -90.73M | -88.81M | -71.04M | -59.35M | -32.5M | -22.22M | -6.55M | -88.32M | -102.92M | -131M |
Selling & General & Admin | 135.74M | 124.38M | 118.3M | 113.12M | 106.82M | 108.41M | 102.24M | 94.07M | 89.16M | 78.86M | 74.49M | 76.1M | 76.92M | 75.49M | 72.15M | 69.94M | 68.87M | 67.94M | 67.07M | 63.79M | 58.61M | 52.92M |
Research & Development | 223.51M | 220.45M | 197.1M | 187.29M | 171.98M | 149.76M | 127.64M | 102.84M | 80.81M | 67.04M | 61.06M | 58.4M | 57.1M | 55.11M | 53.46M | 52.5M | 51.5M | 52.26M | 50.08M | 45.13M | 39.36M | 33.52M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 359.25M | 344.84M | 315.39M | 300.41M | 278.8M | 258.17M | 229.88M | 196.91M | 169.97M | 145.9M | 135.54M | 134.5M | 134.02M | 130.6M | 125.61M | 122.43M | 120.37M | 120.19M | 117.15M | 108.92M | 97.98M | 86.44M |
Interest Expense | 11.4M | 11.63M | 11.83M | 12.11M | 12.33M | 12.51M | 13.58M | 14.62M | 14.82M | 13.62M | 11.34M | 9.03M | 7.4M | 7.11M | 7.02M | 6.86M | 6.72M | 6.68M | 6.67M | 6.72M | 6.78M | 6.81M |
Selling & Marketing Expenses | 59.9M | 44.14M | 29.13M | 17.49M | 14.97M | 23.45M | 23.15M | -4.64M | -14.21M | -13.05M | -13.12M | 23.89M | 33.07M | 32.05M | 39.92M | 38.53M | 37.92M | 36.17M | 35.19M | 32.86M | 29.81M | 27.57M |
Cost & Expenses | 365.96M | 351.48M | 321.97M | 306.62M | 284.8M | 263.73M | 235.5M | 202.7M | 175.57M | 151.29M | 140.83M | 139.41M | 138.62M | 135.05M | 130.15M | 127.07M | 125.24M | 125.01M | 121.56M | 112.89M | 101.09M | 88.6M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 224.95M | 224.1M | 222.92M | 183.92M | 172.59M | 169.4M | 168.02M | 166.99M | 165.82M | 132.02M | 105.92M | 79.37M | 78.05M | 77.39M | 77.01M | 76.98M | 76.76M | 76.75M | 76.62M | 76.55M | 76.32M | 76.07M |
Shares Outstanding (Diluted) | 224.95M | 224.1M | 222.92M | 183.92M | 172.59M | 169.4M | 168.02M | 166.99M | 165.82M | 132.02M | 108.81M | 85.14M | 78.05M | 77.39M | 82.78M | 76.98M | 82.53M | 82.51M | 82.39M | 85.45M | 82.09M | 87.25M |
EPS (Basic) | -1.42 | -1.46 | -1.44 | -1.44 | -1.28 | -1.15 | -1.26 | -1.18 | -1.23 | -1.23 | -1.13 | -1.17 | -1.21 | -1.22 | -1.07 | -1.06 | -1.01 | -1.01 | -1.04 | -2.01 | -1.94 | -2.31 |
EPS (Diluted) | -1.42 | -1.46 | -1.44 | -1.44 | -1.28 | -1.15 | -1.26 | -1.17 | -1.20 | -1.20 | -1.10 | -1.14 | -1.20 | -1.19 | -1.02 | -1.01 | -0.93 | -0.93 | -0.95 | -1.93 | -1.87 | -2.26 |
EBITDA | -284.59M | -274.24M | -249.78M | -233.54M | -200.5M | -176.35M | -176.14M | -155.92M | -119.81M | -98.23M | -66.42M | -55.51M | -81.19M | -79.67M | -61.91M | -50.3M | -23.51M | -13.21M | 2.54M | -79.08M | -93.55M | -121.5M |
EBIT | -290.04M | -278.87M | -254.11M | -237.57M | -204.42M | -180.2M | -179.93M | -159.72M | -123.54M | -101.65M | -69.4M | -58.03M | -83.33M | -81.71M | -64.02M | -52.49M | -25.78M | -15.54M | 119K | -81.6M | -96.14M | -124.19M |
Depreciation & Amortization | 5.45M | 4.63M | 4.33M | 4.03M | 3.92M | 3.85M | 3.79M | 3.79M | 3.72M | 3.42M | 2.98M | 2.52M | 2.14M | 2.04M | 2.11M | 2.19M | 2.27M | 2.33M | 2.42M | 2.52M | 2.59M | 2.69M |
Add to Watchlist
Select watchlists to add or remove OCUL